Casey Cosgrove

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study”.

Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.01.025

N/A

2.5DataRank · unranked

85 citations

Virginia L. Filiaci, Adrianne Mallen, Kristina W. Thiel, Eric J. Devor, Katherine Moxley +17 more

The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women

Gynecologic Oncology(2021)10.1016/j.ygyno.2020.12.040

N/A

0.941DataRank · unranked

26 citations

Wei Deng, Richard J. Zaino, Matthew A. Powell, Camille C. Gunderson, Casey Cosgrove +15 more

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

Communications Biology(2022)10.1038/s42003-022-03978-6

N/A

0.607DataRank · unranked

15 citations

John F. Pearson, Louise Marquart, Joe Dennis, George A. R. Wiggins, Daniel R. Barnes +95 more

Molecular characterization of mixed-histology endometrial carcinoma provides prognostic and therapeutic value over morphologic findings

npj Precision Oncology(2025)10.1038/s41698-025-00803-1

N/A

0.373DataRank · unranked

11 citations

Ashwini Esnakula, Courtney Riedinger, Adrian A. Suarez, Jessica L. Gillespie, Ashley Patton +4 more

Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.08.005

N/A

0.360DataRank · unranked

10 citations

Wei Deng, Richard J. Zaino, Matthew A. Powell, Camille Gunderson Jackson, Casey Cosgrove +14 more

High pre-treatment neutrophil-to-lymphocyte ratio as a prognostic marker for worse survival in patients with recurrent/metastatic cervical cancer treated with immune checkpoint inhibitors

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101040

N/A

0.312DataRank · unranked

7 citations

David A. Mix Barrington, Morgan Brown, Lynette Gonzalez, Jae Suk Baek, Allison Huffman +10 more

A working group report from the 2024 National Cancer Institute / Gynecologic Cancer Steering Committee endometrial cancer clinical trials planning meeting: refining the approach to endometrial cancer in the immunotherapy era

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf089

N/A

0.269DataRank · unranked

5 citations

Dmitriy Zamarin, José R. Conejo-García, Kari Hacker, Roberto Vargas, Panagiotis A. Konstantinopoulos +6 more

Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.094

N/A

0DataRank · unranked

0 citations

Danielle Enserro, Heather A. Lankes, Kyle C. Strickland, Rebecca A. Previs, Matthew Powell +19 more

Characterization of mismatch‐repair/microsatellite instability‐discordant endometrial cancers

Cancer(2023)10.1002/cncr.35030

N/A

0DataRank · unranked

79 citations

Ashwini Esnakula, Paulina Haight, Adrian A. Suarez, Wei Chen, Jessica L. Gillespie +6 more

Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.03.026

N/A

0DataRank · unranked

6 citations

Chunqiao Tian, Jordyn Tumas, Neil T. Phippen, Christopher M. Tarney, Erica Hope +22 more

Exploring endometrial cancer risk stratification by copy number assessment

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.037

N/A

0DataRank · unranked

2 citations

Adrian A. Suarez, Paulina Haight, Alyssa Villacres, Alexis Chassen, Keith Brownewell +5 more

Exploratory evaluation of immunotherapy response and medication use in endometrial and cervical carcinoma

Gynecologic Oncology Reports(2025)10.1016/j.gore.2025.101782

N/A

0DataRank · unranked

0 citations

Molly Morton, Eric McLaughlin, Anna Gonzalez, Jessica Fulton, Jessica Sciuva +11 more